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Background: Balanced complex translocations (BCTs) are rare events, they may result in reproductive failures:
spontaneous abortions, missed abortions, stillbirths, congenital malformations in children, and male infertility. BCTs
belong to the group of complex chromosome rearrangements (CCRs) – up to date about 260 cases were
described.
Results: The described patient and her husband were referred to genetic counseling clinic because of four
reproductive failures. GTG-banded chromosome analysis revealed presence of apparently balanced complex
translocation t(2;5;13), which was verified and confirmed by molecular cytogenetics with single copy probes. This
complex aberration was most likely responsible for reproductive failures in our patient. Since no high resolution
molecular karyotyping (microarrays) was used, this rearrangement can only be considered to be balanced at
cytogenetic level.
Discussion: Due to small number of reported cases of CCRs/BCTs and individual as well as unique character of
such rearrangements, genetic counseling for CCRs carriers is complex and requires detailed pedigree analysis, as
well as extended clinical and genetic testing.
Keywords: Balanced complex translocation (BCT), Complex chromosome rearrangement (CCR), Reciprocal
chromosomal translocation (RCT), Reproductive failure, Conventional cytogenetics (CC), Fluorescence in situ
hybridization (FISH)Background
Reciprocal chromosomal translocations (RCTs) are struc-
tural aberrations which occur as a result of exchange of
chromosome fragments, usually between two nonhomolo-
gous chromosomes. When the amount of genetic compo-
nent is balanced the aberration usually has no influence on
patient’s phenotype [1]. Balanced complex translocation
(BCT) occurs when more than two chromosomes are in-
volved in the translocation [2,3]. BCTs belong to the group
of complex chromosome rearrangements (CCRs) [4]. In
general population BCTs occur rarely, that is why every
new described case can bring more information on possible* Correspondence: elazarczyk@poczta.onet.pl
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unless otherwise stated.consequences of carrying this rearrangement [3,5]. About
260 cases of CCRs have been reported up to date [6-10]. In
most of the carriers of such complex translocations, repro-
ductive failures, including spontaneous abortions, still-
births, delivering children with congenital malformations,
and male infertility were present [1,3,4,6,11-13].
There are several different definitions and classifica-
tions of CCRs used in the literature, most of which base
on the number of chromosomes and the number of
breaks involved. Most of them originate de novo, how-
ever they can be also hereditary, in both balanced and
unbalanced forms. The carrier status is typically revealed
due to pregnancy failures. In 2012 Madan divided CCRs
into four groups [14]. In the type I of CCRs number of
chromosomal breaks equals number of chromosomes in-
volved in an aberration and the exchange can be three-al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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one more than number of involved chromosomes; this
type also contains inversion. In the type III, number of
breaks is greater than number of involved chromosomes,
with the presence of at least one insertion. In the type
IV, apart from number of breaks greater than number of
chromosomes the occurrence of ‘middle segment’ is ob-
served. ‘Middle segment’ means fragment of a chromo-
some located in the middle of derivative chromosome,
flanked bilaterally by fragments of different chromo-
somes. In this type of CCRs at least one of derivative
chromosomes is composed of three different chromo-
somes. This type also includes more complex rearrange-
ments, with multiple breakpoints and more than one
‘middle segment’ [14]. In 2013 Madan proposed a new
approach to CCRs’ classification. She concluded that in
de novo cases in phenotypically abnormal individuals the
significance of the detected imbalance and its pheno-
typic effect should be emphasized. However in familial
cases it is still important to describe number of chromo-
somes and breaks involved [8].
Most of the cases of CCRs occur de novo (~70%) and
the remaining ones are usually transmitted by mothers [7].
Case presentation
25-year old woman and her husband were referred to
clinical genetics unit due to four pregnancy failures. First
pregnancy (anencephalic) was terminated at 19th week of
gestation. At 6th week of the second pregnancy blighted
ovum was found. Third pregnancy underwent spontan-
eous abortion at 6th week of gestation. The fourth preg-
nancy was extrauterine.
The physical examination did not reveal any pheno-
typic abnormalities or any congenital malformations in
either partner.
A history of reproductive problems was reported in ma-
ternal family members (see Figure 1 showing pedigree).
Our patient’s mother had difficulties to conceive, her sec-
ond pregnancy was spontaneously aborted. She also gaveFigure 1 Patient’s pedigree. Arrow indicates proband. Proband’s
mother and husband are indicated by an asterisk. Only these family
members were tested. ‘N’ means normal karyotypes. Only in
proband both cytogenetic and FISH testing were performed.birth to a girl who died before the age of one month due
to congenital malformations. The only sister of patient’s
mother has one son with heart defect and one healthy
daughter. The wife of the brother of patient’s mother had
two spontaneous abortions. Maternal grandmother had
one spontaneous abortion.
Patient’s father has two healthy sons from his second
relationship. Wife of father’s brother underwent a spon-
taneous abortion of her only pregnancy. Paternal history
was otherwise unremarkable.
Family of patient’s husband did not have any history of
reproductive health problems.
Results
Classical cytogenetic examination revealed translocation
involving chromosomes 2, 5 and 13. Karyotype of the pa-
tient was established as 46, XX, t(2;5;13) (p21;p15.1;q22)
(Figure 2). Karyotypes of patient’s husband and mother
were normal (data not shown).
FISH technique with whole chromosome painting
(wcp) probes: wcp2, wcp5, wcp13, and specific probes:
D13S1825, N-MYC, DLEU1, CTNND2 performed in our
patient confirmed the presence of complex translocation
involving three chromosomes.
Combined GTG-banded metaphase spreads and FISH
images illustrating the complex character of this re-
arrangement are presented in Figures 3 and 4.
Probability of unbalanced karyotype in a child was es-
timated as 2% (low risk) to 13% (high risk), depending
on the type of imbalance. Risk of miscarriages was esti-
mated at around 30%.
No other genetic testing was performed due to the
lack of microarray technology in our laboratory.
Discussion
The aberration found in our patient was most likely re-
sponsible for her reproductive health problems. LiteratureFigure 2 Karyogram of the patient in GTG-banding showing t
(2;5;13) (p21;p15.1;q22). Arrows indicate abnormal chromosomes.
Figure 3 Combined images of CC and FISH with painting probes. A. Metaphase spread in GTG-banding obtained from patient’s blood
lymphocytes showing t(2;5;13) (p21;p15.1;q22). Arrows show abnormal chromosomes. B. The same metaphase as in Figure 3A in FISH technique
with painting probes: chromosome 2-green, 5-red. Material from der(2) is present on der(5) while material from der(5) is present on der(13).
Arrows show abnormal chromosomes. C. The same metaphase as in Figure 3A and 3B in FISH technique with painting probes: 13-green, 5-red.
Material from der(13) is present on der(2), while material from der(5) on der(13). Arrows show abnormal chromosomes.
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BCT carriers is higher than in carriers of RCT [2-4].
Presence of abnormal phenotypic features could be
associated with microdeletions or microduplications
accompanying BCT or could be a position effect ofFigure 4 Combined images of CC and FISH with single copy probes. A
Arrows show abnormal chromosomes. B. The same metaphase as 4A with
of N-MYC signals is present on der(5). Arrows show abnormal chromosome
critical region probe – CTNND2 (5p15.2) – red. Control region, 5q13 – green. O
chromosomes 5 and 13. D. The same metaphase as 4A, 4B and 4C, with DLEU
present on normal 13 chromosome. The second DLEU1 signal is present on d
chromosomes 2 and 13.genes located at or flanking the breakpoints involved in
aberrations [15].
Gorski et al. estimated the risk of spontaneous abor-
tions in BCT carriers at 48.3% and the risk of child mal-
formations at 18.4% [16]. These data are cited by most. Metaphase spread in GTG banding showing t(2;5;13) (p21;p15.1;q22).
N-MYC (2p24) probe in red (control gene – LAF (2q11) – green). One
s 2 and 5. C. The same metaphase as 4A and 4B, with cri-du-chat
ne of the CTNND2 signals is visible on der(13). Arrows show abnormal
1 probe (13q14.3) – red. Control region, 13qter, is green. Both signals are
er(13), and the second control signal on der(2). Arrows show abnormal
Figure 5 Schematic representation of hexavalent of meiotic
chromosomes involved in t(2;5;13) (p21;p15.1;q22).
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CCR should be considered separately and should require
individual approach at genetic counseling due to the lack
of reproducibility in general population.
In carriers of CCRs more complex mechanisms of
chromosome segregation occur in comparison to transloca-
tions involving two chromosomes [2]. Among these mech-
anisms non-allelic homologous recombination (NAHR)
is widely proposed. Alternative mechanisms include non-
homologous end-joining (NHEJ) or microhomology-
mediated break-induced replication (MMBIR). It has also
been proposed that a molecular mechanism similar
to chromothripsis (occurrence of different rearrangements
in a single chain chromosome breakage event) can be
involved [17].
Translocation described in our patient belongs to
three-way, three breakpoints exchange CCR, with one
breakpoint on each involved chromosome. In 80% of
cases from this group, the most expected type of segre-
gation is 3:3, which can determine the formation of 20
types of gametes: 2 balanced and 18 unbalanced. Ac-
cording to the literature, 4:2 segregation is also possible
in about 20% of cases [4].
To our knowledge, only one case involving the same
chromosomes as seen in our patient (but with different
breakpoints – 2q14.2, 5q22-q23.2, and 13q34) has been
described so far [18].
Most of the cases of CCRs are unique, ‘private’ for their
carriers or carriers’ families. They are also very rare events,
with frequency estimated around 0.1% (frequency of cou-
ples with recurrent spontaneous abortion in which one
partner carries a balanced translocation between three
chromosomes) [19]. The possibility of chromosomally
normal or balanced gametes is considered to be low,
which can be calculated from the theoretical hexavalent
configuration during meiotic cell division (Figure 5).
This complex structural rearrangement can result in
partial monosomies or trisomies of involved chromo-
somes. Not surprisingly, they can result in variable phe-
notypes. In patients with familial form of partial trisomy
of 2p, neural tube disorders were present, including an-
encephaly, occipital encephalocele or spina bifida [20].
Partial monosomies of 2p are rare. Microcephaly was
noted when deletion spanned 2p23-pter region [21].
Microdeletion of 2p15-p16.1 was reported in patient with
cerebellar hypoplasia, intellectual disability, microcephaly,
optic nerve hypoplasia and autistic behaviour [22]. Gen-
eral symptoms present in patients with partial deletions
of short arm of chromosome 2 include developmental
delay, growth retardation, feeding difficulties, axial hypo-
tonia, limbs spasticity and spine anomalies [23].
Clinical result of partial deletion of short arm of
chromosome 5 may be cat cry syndrome (cri du chat).
The most significant symptoms of this syndrome includecharacteristic cry of the newborn (cat-like cry), facial
dysmorphy, microcephaly, severe or profound develop-
mental delay and intellectual disability. Low birth
weight, hypotonia, hypertelorism and epicanthal fold are
listed as additional features of this syndrome. The ‘final’
phenotype of this syndrome usually depends on the size
of deleted region – there are patients in whom cat-like
cry is the only feature present [24].
Phenotype of patients with 5p trisomy can be highly
variable (cytogenetically and molecularly) due to different
duplicated regions of 5p. The most frequent 5p duplica-
tions encompass 5p13-pter region and are associated with
intellectual disability, dolichocephaly, facial dysmorphism,
high arched palate, tongue hypertrophy and micrognathia.
Partial trisomy 5p is usually the result of inheritance from
a parental derivative chromosome, which results from par-
ental balanced reciprocal translocation or parental inver-
sion, less frequently it results from a insertion or a marker
chromosome [24].
Trisomy of 13q is more frequently a result of parental
balanced translocation or pericentric inversion rather than
of de novo duplication [25]. Most of the features present
in patients with partial trisomy 13q are also present in pa-
tients with full chromosome 13 trisomy which results in
Patau syndrome (PS). However, clinical features of full tri-
somy 13 are more severe due to presence of brain malfor-
mations, cardiovascular defects and renal anomalies. In
about 80% of PS patients holoprosencephaly with charac-
teristic dysmorphy of midface (e.g. proboscis), cleft lip and
palate, small dysplastic earlobes, microcephaly, and hypo-
telorism are also present [25,26]. In patients with partial
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when trisomic region includes 13q11-q14 [26].
In partial 13q monosomy phenotypes vary in regard to
size and location of a deleted fragment. Severe mental re-
tardation, growth retardation, microcephaly, micrognathia,
microphthalmia, cleft palate, absent thumbs, and hypoplas-
tic kidneys are the phenotypic features of this aberration.
Postaxial polydactyly is associated to loss of 13q21-q32
region [27].
Conclusions
The genetic risk of having children with congenital anom-
alies and the risk of pregnancy losses is in our patient at
the high level (2-13% and 30%, respectively). This results
from the complexity of possible combinations of chromo-
some losses and gains. She has a chance of having healthy
child, because only one homolog of each chromosome
pairs 3, 5 and 13 is involved in the translocation.
It can be stated on cytogenetic/FISH level only that
the aberration present in our patient is balanced. It is
crucial to characterise and analyse the breakpoints with
greater details as some congenital malformations may
arise due to a disruption of key genes involved in devel-
opment of pregnancy.
It is difficult to predict the likely phenotypic outcome of
any future pregnancies or children of described patient, as
many different forms of chromosome imbalances may
occur in her gametes. Thus, genetic counseling may be
very difficult and complex. The patient should be offered
invasive prenatal diagnosis in future pregnancies.
As the presence of any chromosomal rearrangement
was excluded in the patient’s mother by standard cyto-
genetic analysis, reproductive failures in members of ma-
ternal line are not relevant to this case. They, most likely
coincide with the carrying of t(2;5;13) by the patient.
The origin of the translocation, paternal or de novo,
could not be established due to the lack of consent of
patient’s father for the cytogenetic examination.
Despite the wide usefulness of microarray technology in
detecting genome imbalances in apparently balanced
chromosomal rearrangements, some laboratories still have
no access to this technology. The authors will continue to
investigate this case using array CGH technique.
This case does not provide any major breakthrough,
however we strongly believe that it is still worth to pub-
lish every case of CCR due to its unique character as
it has been proposed by Guilherme et al.: ‘a better
characterization of the CCRs is important for a better
knowledge of their mechanisms of formation and their
relevance to phenotype’ [17].
Materials and methods
5 ml of peripheral blood was taken from each: the pa-
tient, her husband and mother. The patient’s father didnot give his consent for blood sample. Blood cells were
cultured according to standard procedures. Cytogenetic
slides were stained with GTG banding technique and de-
scribed according to ISCN 2013.
GTG-banded chromosomes analysis revealed trans-
location involving chromosomes 2, 5 and 13. In order to
confirm the three-way character of this abnormality,
fluorescence in situ hybridization (FISH) was performed.
The following molecular probes were used: whole chromo-
some painting probes (wcp) for chromosomes 2, 5 and
13 (Cytocell, UK), and specific probes – D13S1825 (Cyto-
cell, UK), N-MYC (2p24) (Kreatech Diagnostics, Holland),
critical region for cri-du-chat CTNND2 (5p15.2) (Kreatech
Diagnostics, Holland) and DLEU1 (13q14.3) (Cytocell,
UK). FISH analyses were performed according to manu-
facturers’ procedures. Images were analysed with Spectral
Imaging system with FISH module (Applied Spectral
Imaging, USA).
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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